ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Commerce Dept. Open Radiation Standards Facility For Mammography Calibration

April 4, 1996

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994